Shenzhen Bioeasy Biotechnology Co. Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004C78
CNY
8.56
0.22 (2.64%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
76.17
59.85
49.34
66.20
54.40
67.17
36.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
76.17
59.85
49.34
66.20
54.40
67.17
36.48
Raw Material Cost
27.43
18.75
26.92
14.83
23.63
26.33
12.34
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.91
6.35
6.42
6.59
3.80
2.88
5.39
Selling and Distribution Expenses
27.12
26.77
18.83
25.93
21.20
28.38
20.53
Other Expenses
0.43
0.34
0.02
0.47
0.45
0.53
0.32
Total Expenditure (Excl Depreciation)
65.77
55.27
52.38
52.04
53.15
62.89
41.50
Operating Profit (PBDIT) excl Other Income
10.4
4.6000000000000005
-3
14.2
1.2
4.3
-5
Other Income
14.17
8.34
6.42
12.38
10.83
6.69
5.26
Operating Profit (PBDIT)
24.42
19.06
9.15
28.64
16.07
17.90
7.24
Interest
6.91
6.35
6.42
6.59
3.80
2.88
5.39
Exceptional Items
-0.02
0.65
0.90
-0.36
1.88
0.27
0.09
Gross Profit (PBDT)
48.74
41.10
22.42
51.37
30.77
40.84
24.14
Depreciation
0.00
6.14
6.14
4.42
4.42
7.10
7.10
Profit Before Tax
17.63
7.22
-2.51
17.28
9.73
8.18
-5.17
Tax
-0.57
-0.44
-0.80
1.34
1.02
0.77
-0.06
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
15.68
5.69
-3.35
13.22
5.46
5.55
-7.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
15.68
5.69
-3.35
13.22
5.46
5.55
-7.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
1.23
0.44
-0.89
0.41
-0.52
-0.23
-0.16
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.92
6.12
-4.23
13.63
4.94
5.32
-7.27
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
908.09
864.39
865.76
869.01
852.89
847.48
841.86
Earnings per share (EPS)
0.04
0.01
-0.01
0.03
0.01
0.01
-0.02
Diluted Earnings per share
0.04
0.01
-0.01
0.03
0.01
0.01
-0.02
Operating Profit Margin (Excl OI)
13.46%
7.65%
-6.91%
17.89%
1.51%
6.11%
-14.04%
Gross Profit Margin
23.15%
22.33%
7.37%
32.77%
26.01%
22.75%
5.3%
PAT Margin
20.59%
9.5%
-6.78%
19.97%
10.03%
8.26%
-19.5%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 27.42% vs 21.30% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 177.05% vs 245.24% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -4.67% vs 296.30% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 9.52% vs -1.56% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Shenzhen Bioeasy Biotechnology Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
76.17
0
76.17
Other Operating Income
0.00
0.00
0.00
Total Operating income
76.17
0
76.17
Raw Material Cost
27.43
0
27.43
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.91
0
6.91
Selling and Distribution Expenses
27.12
0
27.12
Other Expenses
0.43
0.00
0.43
Total Expenditure (Excl Depreciation)
65.77
0
65.77
Operating Profit (PBDIT) excl Other Income
10.40
0.00
10.40
Other Income
14.17
0
14.17
Operating Profit (PBDIT)
24.42
0
24.42
Interest
6.91
0
6.91
Exceptional Items
-0.02
0
-0.02
Gross Profit (PBDT)
48.74
0
48.74
Depreciation
0.00
0
0.00
Profit Before Tax
17.63
0
17.63
Tax
-0.57
0
-0.57
Provisions and contingencies
0
0
0.00
Profit After Tax
15.68
0
15.68
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
15.68
0
15.68
Share in Profit of Associates
0
0
0.00
Minority Interest
1.23
0
1.23
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.92
0
16.92
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
908.09
0
908.09
Earnings per share (EPS)
0.04
0
0.04
Diluted Earnings per share
0.04
0
0.04
Operating Profit Margin (Excl OI)
13.46%
0%
0.00
13.46%
Gross Profit Margin
23.15%
0%
0.00
23.15%
PAT Margin
20.59%
0%
0.00
20.59%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7.62 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 27.42% vs 21.30% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 40.07% vs 2.64% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.69 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 177.05% vs 245.24% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 244.90% vs 116.61% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1.02 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -4.67% vs 296.30% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 96.15% vs 271.43% in Sep 2024

Quarterly - Interest
Interest 0.69 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 9.52% vs -1.56% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 81.58% vs 280.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.46%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024